What Is a Peptide? Beyond the Hype

Where this course starts

If you've stumbled into the world of peptides through a podcast, a fitness influencer, a longevity newsletter, or a doctor's recommendation, you've probably encountered something like this: a bunch of letter-and-number combinations (BPC-157, TB-500, GLP-1), bold claims about what they can do, and very little clarity about what these things actually are.

This first lesson fixes that.

By the end of the next 9 minutes, you'll have a solid working definition of what a peptide is, you'll know three peptides your body produces right now without any input from you, you'll understand why the field is exploding in 2026 (it's not the reason most people think), and you'll have a mental map of the four functional categories this course will take you through over the next four weeks.

No biology background needed. No hype.

The definition that actually matters

A peptide is a short chain of amino acids — typically fewer than 50 — linked together by chemical bonds called peptide bonds.

That's it. That's the whole thing.

If the chain is longer than ~50 amino acids, we start calling it a protein. The boundary is fuzzy — some sources put it at 40, some at 50, some at 100 — but the underlying point is the same: peptides are short, proteins are long, and they're made of the exact same building blocks (amino acids).

Think of amino acids as letters in an alphabet. Your body uses 20 standard amino acids (think A through T). A peptide is a short word or phrase built from those letters. A protein is a paragraph. Both use the same alphabet. The difference is length and complexity.

Why the length distinction matters: Short chains fold differently than long ones. Peptides can squeeze into receptor binding sites that whole proteins can't access. This is why peptides are so often used for signaling — they're small enough to slip into the right molecular keyhole.

Three peptides your body is making right now

Here's the thing most people don't realize: peptides aren't some exotic external compound. Your body produces thousands of them every day, and several of them are running your life right now.

Insulin is a peptide. It's 51 amino acids long (right at the peptide/protein boundary, technically — some textbooks call it a small protein). Without it, your blood sugar can't get into your cells, and you die within days. Type 1 diabetics inject a peptide drug — synthetic insulin — to replace what their pancreas can't make. This has been happening since 1922.

Oxytocin is a peptide. Just 9 amino acids. It's the molecule released during childbirth, breastfeeding, sex, and social bonding. Your hypothalamus is producing it as you read this. It's been FDA-approved for inducing labor since 1980.

GLP-1 (glucagon-like peptide-1) is a peptide. 30 amino acids. Your gut releases it after you eat. It tells your pancreas to release insulin, slows down stomach emptying, and signals fullness to your brain. The drug semaglutide (sold as Ozempic and Wegovy) is a longer-lasting synthetic version of GLP-1. It's a peptide drug. The most commercially successful drug launch in pharmaceutical history is a peptide.

So when someone says "peptides are new" or "peptides are unproven," they're showing they don't know what a peptide is. Insulin is a peptide. The bestselling weight loss drug in history is a peptide. The conversation we need to have isn't whether peptides work — it's which specific peptides have good evidence behind them, in what specific contexts, for what specific outcomes. That's what the rest of this course is about.

Why peptides are having a moment in 2026

There's a real reason peptide content is everywhere right now, and it's not what most people assume.

The mainstream peptide moment didn't start with biohackers or longevity podcasters. It started in 2017, when the FDA approved semaglutide for type 2 diabetes. It accelerated in 2021 when semaglutide was approved for weight management (Wegovy). And it became a cultural phenomenon in 2023-2024 when GLP-1 drugs became the most talked-about pharmaceutical class since statins.

Once the public understood that the blockbuster weight loss drug was, technically, a peptide, the obvious question followed: what else is in this category?

Layer in two more factors. In 2023, the FDA placed 19 widely-used research peptides (including BPC-157 and TB-500) on a restricted compounding list, cutting off legal access through compounding pharmacies. In 2026, HHS Secretary Robert F. Kennedy Jr. began publicly advocating for those peptides to be reclassified — and the FDA scheduled formal review meetings for July 23-24, 2026 to evaluate seven of them.

The result: an entire field that had been operating in the shadows of medicine for decades is now getting mainstream coverage from outlets like Scientific American, The Wall Street Journal, and BioSpace.

This is the most important window in peptide education we've ever had. If you understand the field now, you'll be ahead of nearly everyone — including, in many cases, your own physicians.

The four functional categories (your course map)

The peptides this course covers fall into four broad functional categories. Knowing this map upfront will make everything that follows easier to navigate.

1. Healing & Recovery Peptides. Compounds that support tissue repair, reduce inflammation, and accelerate recovery from injury. The headliners here are BPC-157, TB-500 (technically a fragment of Thymosin Beta-4), and KPV. These are heavily used in athletic and physical-therapy contexts. Strong preclinical evidence base, limited large-scale human trials.

2. Growth Hormone Secretagogues. Peptides that stimulate your pituitary gland to release more of your own growth hormone, rather than injecting growth hormone itself. The most discussed are CJC-1295, Ipamorelin, and Sermorelin (which has actual FDA approval history). Used for body composition, recovery, and anti-aging applications.

3. Longevity & Mitochondrial Peptides. Compounds investigated for their potential effects on aging biology — telomere length, mitochondrial function, immune modulation. Includes Epitalon, Humanin, MOTS-C, and Thymalin. This is the most speculative category in terms of human evidence, but mechanistically the most interesting.

4. Cognitive & Neuro Peptides. Compounds with effects on the brain — anxiety, focus, mood, neuroplasticity. Selank, Semax, Cerebrolysin, and Dihexa lead this category. Russian research dominates this space (much of the original work was Soviet-era).

A fifth category — Metabolic & GLP-1 Peptides — bridges into FDA-approved territory: semaglutide, tirzepatide, retatrutide. We'll cover these too because they're the most clinically validated peptides in modern medicine.

Over the next 19 lessons, you'll get a working understanding of each of these categories: how the compounds work, what the actual evidence says, what the regulatory status is, and how to evaluate any claim you encounter about them.

A note on intellectual honesty

There's something I want to set up now, in Lesson 1, that will shape every lesson that follows.

The peptide field is full of overclaim. You'll find websites that present BPC-157 as a miracle compound based almost entirely on animal studies. You'll find clinics offering protocols at premium prices with no published clinical evidence. You'll find biohacking communities treating preclinical data as if it were proof of safety and efficacy in humans.

You'll also find the opposite — physicians dismissing peptides entirely because they don't have FDA-approved indications, ignoring decades of foreign clinical research and substantial preclinical literature.

Both extremes are wrong.

The honest position — the one this course is built on — is that peptides represent one of the most promising and underexplored areas of modern medicine, but the gap between what we know and what's claimed is enormous, and learning to navigate that gap is the actual skill worth building.

By the end of Week 1, you'll have the framework to evaluate any peptide claim you encounter. By the end of the course, you'll have a defensible personal strategy and the vocabulary to have an informed conversation with any clinician.

That's the goal. Let's go.